An international team of researchers led by Dr. Eleanor Fish, Scientist Emeritus at the Toronto General Hospital Research Institute, UHN, and professor in the University of Toronto‘s Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.
According to the new study, published Friday in Frontiers in Immunology, treatment with interferon(IFN)- a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.
The research team found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days. It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.
Dr. Fish says the research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.
“Rather than developing a virus-specific antiviral for each new virus outbreak, I would argue that we should consider interferons as the ‘first responders’ in terms of treatment,” says Dr. Fish.
“Interferons have been approved for clinical use for many years, so the strategy would be to ‘repurpose’ them for severe acute virus infections.”
Boosting a natural defence mechanism
Interferons are a group of signaling proteins released by the human body in response to all viruses. As Dr. Fish explains, they are a “first line of defence.”
They target different stages of a virus’s life cycle, inhibiting them from multiplying. They also boost an immune response by activating different immune cells to clear an infection. Some viruses, however, can block this natural defense mechanism.
“But it is possible to override this block. If a virus blocks interferon production, then treating with interferon can offset this.”
The researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China. These patients were admitted to Union Hospital, Tongii Medical College, between January 16 and February 20, 2020. They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.
Despite the study’s limitations of a small, non-randomized group of patients, the work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.
Dr. Fish says a randomized clinical trial is a crucial next step. According to her, a clinical trial with a larger group of infected patients who are randomized to treatment or placebo would further this research.
In the meantime, the findings from this study are the first to suggest therapeutic efficacy of IFN-a2b as an available antiviral intervention for COVID-19, which may also benefit public health measures by shortening the duration of viral clearance and therefore slowing the tide of the pandemic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Recovery of COVID-19 patients
- Researchers observe lung recovery even in critically ill Covid-19 patients after 3 monthson November 27, 2020 at 10:29 am
According to a study carried out by the researchers at Radboud University, most cases of critically ill Covid-19 patients show signs of recuperating lung tissue. The researchers through their study ...
- BRIEF-Colchicine To Be Investigated As Possible Treatment For COVID-19 In Recovery Trialon November 27, 2020 at 6:15 am
COLCHICINE TO BE INVESTIGATED AS A POSSIBLE TREATMENT FOR COVID-19 IN THE RECOVERY TRIAL * RECOVERY TRIAL -ANTICIPATED THAT AT LEAST 2500 PATIENTS RECRUITED TO RECOVERY TRIAL WILL BE RANDOMLY ...
- Immunonutrition may improve COVID-19 patients' recoveryon November 26, 2020 at 7:30 pm
Researchers duo Emma Derbyshire and Joanne Delange from the Nutritional Insight, Surrey, United Kingdom, explore the role of immunonutrition – nutrition that boosts or influences the immune system for ...
- Lungs of COVID-19 patients show good recovery in most caseson November 25, 2020 at 6:43 pm
Lung tissue of patients who suffered severely from COVID-19 shows good recovery in most cases. This was revealed by a study carried out by the Radboud university medical center that has now been ...
- Where do homeless patients go after being treated for COVID-19?on November 25, 2020 at 12:09 pm
That’s not all of the city’s homeless, of course; the 60,000-plus doesn’t include homeless people hidden within patient rolls and emergency department waiting rooms. In 2019, the city’s annual count ...
Go deeper with Google Headlines on:
Recovery of COVID-19 patients
Go deeper with Bing News on:
- Resveratrol shows potential as SARS-CoV-2 antiviral, study findson November 27, 2020 at 9:43 am
A recent study reveals that resveratrol, a phenolic compound produced by spermatophytes, can inhibit the viral replication SARS-CoV-2.
- Antiviral Drugs Market to Deliver Prominent Growth & Striking Opportunities, Analysis, Demand, Growth by Top Key Players, Forecast 2026on November 26, 2020 at 3:46 pm
Nov (The Expresswire) -- Global"Antiviral Drugs Market"(2020-2026) status and position of worldwide and key regions, with perspectives ...
- Growth Outlook: Antiviral Therapies Market Expand their Businesses with New Investmenton November 25, 2020 at 2:43 am
Research Dive :Post COVID-19 Impact on Antiviral Therapies Market. With the emergence of the COVID-19 crisis, the world is fig ...
- This Drug Is a Staple of COVID Treatment. Should It Be?on November 24, 2020 at 6:02 am
An extremely popular antiviral got dissed by the World Health Organization after months of use in the U.S. and elsewhere. What happened?
- Antiviral Drug Market | 2020 Global Industry Analysis By Size, Share Estimation, Growth Rate, Trends And Forecast To 2026on November 21, 2020 at 12:08 am
Antiviral Drugs Market 2020 Global Covid-19 Impact Analysis on Healthcare Sector And Business With Forecast To 2026 ...